KdT Ventures

KdT Ventures is a seed-stage venture capital firm that specializes in investing at the intersection of technology and science. They focus on early-stage companies, often being the first to invest, with a unique model that aims to have a significant impact on the earliest stages of a venture. Their investment philosophy centers on re-architecting the world at a molecular level, addressing the physical layer that has remained largely unchanged despite advancements in computation.

Notable portfolio companies include 54Gene, Asimov, Dyno Therapeutics, and PathAI, which have collectively raised substantial funding. KdT Ventures is led by key partners who bring extensive experience and networks to the table, offering unique value-add services to their portfolio companies. These services include strategic guidance, operational support, and access to a broad network of industry experts and potential collaborators, helping startups navigate their growth and development phases effectively.